Related Experiment Video
Updated: Jul 12, 2025

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
Published on: July 21, 2023
The Association between Birthweight and Use of Cardiovascular Medications: The Role of Health Behaviors
Minjia Mo1, Robert Thiesmeier2, George Kiwango2,3
1Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, 14183 Stockholm, Sweden.
Insights
Low birthweight is linked to increased use of cardiovascular medications in adulthood. Maintaining healthy behaviors can mitigate this risk, even for those with low birthweight.
Area of Science:
- Cardiovascular medicine
- Public health
- Perinatal research
Background:
- Limited evidence exists on low birthweight's impact on cardiovascular medication use and health behaviors.
- Investigating the independent and combined effects of birthweight and adult health behaviors on medication needs is crucial.
Purpose of the Study:
- To determine the independent effect of low birthweight on cardiovascular medication use.
- To assess the combined impact of low birthweight and adult health behaviors on cardiovascular medication use.
Main Methods:
- Utilized data from 15,618 participants with birthweight and health behavior information.
- Cardiovascular medications were identified via the Prescribed Drug Register using Anatomical Therapeutic Chemical codes (C01-C10, B01).
- Multinomial logistic regression models were employed to analyze medication use (0, 1, or ≥2 types).
Main Results:
- Low birthweight was associated with a higher odds ratio (OR) for using ≥2 types of cardiovascular medications (OR=1.46).
- Poor health behaviors increased the risk of using ≥2 medication types for normal (OR=2.17) and high (OR=1.84) birthweight individuals.
- The highest risk for using ≥2 medication types was observed in individuals with both low birthweight and poor health behaviors (OR=3.14).
Conclusions:
- Low birthweight independently increases the risk of using multiple types of cardiovascular medications in adulthood.
- Adopting healthy lifestyle behaviors can significantly reduce the risk of cardiovascular medication use, even for individuals with low birthweight.
Background:
There is limited evidence on the effect of low birthweight on the use of cardiovascular medications and the role of health behaviors. This study aims to determine the independent effect of low birthweight and its combination with adult health behaviors on the number of dispensed cardiovascular medications.
Methods:
We included 15618 participants with information on birthweight and self-reported health behaviors. Dispensed cardiovascular medications were identified from the Prescribed Drug Register based on a three-digit level Anatomical Therapeutic Chemical classification code (C01 to C10 and B01) and categorized into 0, 1, and ≥2 different types of medications. We applied multinomial logistic regression models estimating odds ratios (ORs) and 95% confidence intervals (CIs).
Results:
Participants with low birthweight had a higher estimated OR of using ≥2 types of cardiovascular medications (OR = 1.46, 95% CI = 1.06, 2.01). Further, an increased risk for using ≥2 types of cardiovascular medications was found in participants with poor health behaviors for normal (OR = 2.17, 95% CI = 1.80, 2.62) and high (OR = 1.84, 95% CI = 1.29, 2.62) birthweight. The strongest effect on using ≥2 types of cardiovascular medications was found for low birthweight and poor health behaviors (OR = 3.14, 95% CI = 1.80, 5.50).
Conclusion:
This cohort study provides evidence that low birthweight increases the risk of using more types of cardiovascular medications in adulthood. This study also suggests that ideal health behaviors reduce this risk.
Related Concept Videos
Lifestyle Factors and Health
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...
Factors affecting Blood pressure
Physiological Factors:
Factors Affecting Drug Response: Overview
Coronary Artery Disease I: Introduction
Cardiovascular Drugs: Classification based on Therapeutic Indications
Hypertension IV: Drug Therapy and Lifestyle Modifications

